logo
Products
Services
Resources
Selection Guides
About
ddCTP
2',3'-Dideoxycytidine-5'-triphosphate; 10 mM in ddH2O
Sanger sequencing, also known as the chain termination method, is a technique for DNA sequencing based upon the selective incorporation of chain-terminating dideoxynucleotides (ddNTPs) by DNA polymerase. It was developed by Frederick Sanger and colleagues in 1977. Although the newer NGS technologies are becoming common in clinical research labs due to their higher throughput capabilities and lower costs per sample, Sanger sequencing with 99.99% accuracy is still the “gold standard” for clinical research sequencing. dd-CTP is one of the four critical ddNTP components for performing Sanger sequencing.
Chemical structure for ddCTP [2',3'-Dideoxycytidine-5'-triphosphate].
CatalogSize
Price
Quantity
172071 umole
Price
 
Physical properties

Molecular weight451.16
SolventWater
Usage and storage

Intended useResearch Use Only (RUO)
StorageFreeze (< -15 °C); Minimize light exposure
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on August 15, 2026